WP Advisors LLC Takes $118,000 Position in SPDR S&P Biotech ETF (XBI)

WP Advisors LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 1st quarter, according to its most recent filing with the SEC. The fund acquired 1,300 shares of the exchange traded fund’s stock, valued at approximately $118,000.

Several other institutional investors and hedge funds have also modified their holdings of XBI. Cranbrook Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $26,000. Gradient Investments LLC bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $27,000. Truewealth LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $29,000. Quattro Financial Advisors LLC lifted its stake in SPDR S&P Biotech ETF by 49.6% in the 4th quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock valued at $31,000 after acquiring an additional 124 shares in the last quarter. Finally, Lehman & Derafelo Financial Resources LLC bought a new stake in SPDR S&P Biotech ETF in the 4th quarter valued at approximately $32,000.

NYSEARCA XBI traded down $1.14 during trading on Monday, hitting $88.76. The stock had a trading volume of 320,092 shares, compared to its average volume of 4,768,354. SPDR S&P Biotech ETF has a 12 month low of $64.38 and a 12 month high of $101.55.

COPYRIGHT VIOLATION WARNING: This article was posted by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.thelincolnianonline.com/2019/04/15/wp-advisors-llc-takes-118000-position-in-spdr-sp-biotech-etf-xbi.html.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also: Why is the conference call important?

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.